ATARA BIOTHERAPEUTICS, INC. Deferred Tax Assets, Operating Loss Carryforwards
ATARA BIOTHERAPEUTICS, INC. (ATRA) had Deferred Tax Assets, Operating Loss Carryforwards of $289.52 million as of 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-16
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $289.52M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $259.38M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $323.58M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $302.59M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $289.52M 10-K · filed 2026-03-16 |
| 2024-12-31 | $259.38M 10-K · filed 2026-03-16 |
| 2023-12-31 | $323.58M 10-K · filed 2025-03-07 |
| 2022-12-31 | $302.59M 10-K · filed 2024-03-28 |
| 2021-12-31 | $309.00M 10-K · filed 2023-02-08 |
| 2020-12-31 | $237.01M 10-K · filed 2022-02-28 |
| 2019-12-31 | $162.44M 10-K · filed 2021-03-01 |
| 2018-12-31 | $91.99M 10-K · filed 2020-02-27 |
| 2017-12-31 | $31.11M 10-K · filed 2019-02-26 |
| 2016-12-31 | $36.91M 10-K · filed 2018-02-27 |
| 2015-12-31 | $24.22M 10-K · filed 2017-03-09 |
| 2014-12-31 | $8.22M 10-K · filed 2016-03-04 |
| 2013-12-31 | $2.87M 10-K · filed 2015-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |